Colomer Bosch, Ramon ramon.colomer@uam.es
Actividades
- Artículos 257
- Libros 4
- Capítulos de libro 3
- Congresos 91
- Documentos de trabajo 1
- Informes técnicos 4
- Proyectos de investigación 1
- Tesis dirigidas 9
- Patentes o licencias de software 0
SERUM CA 15.3 IN FEMALES WITH NONTUMORAL BREAST DISEASE - PRELIMINARY-RESULTS
- RUIBAL, A
- COLOMER, R
- GRIS, JM
- GENOLLA, J;
Medicina Clinica (p. 393-394) - 1/1/1986
- ISSN 00257753
- iMarina
CONCENTRATION OF MYELIN BASIC-PROTEIN IN CEREBROSPINAL-FLUID IN PROGNOSIS OF MULTIPLE-SCLEROSIS
- J Matias-Guiu
- A Ruibal
- JM Martinez-Vazquez
- R Colomer
- A Codina
Clinical Chemistry (p. 915-916) - 1/1/1986
- ISSN 00099147
- iMarina
CRANIAL CT-SCAN IN TRANSIENT GLOBAL AMNESIA
- Matias-Guiu J, Colomer R, Segura A, Codina A
Acta Neurologica Scandinavica (p. 298-301) - 1/1/1986
10.1111/j.1600-0404.1986.tb03280.x Ver en origen
- ISSN 00016314
- iMarina
- iMarina
SERUM CA 15.3 LEVELS IN PATIENTS WITH GENERAL PATHOLOGY AND MALIGNANT DISEASES (EXCLUDING BREAST-CANCER)
- RUIBAL, A
- ENCABO, G
- GENOLLA, J
- GUARGA, A
- URRUTIA, A
- COLOMER, R;
Bulletin Du Cancer (p. 94-95) - 1/1/1986
- ISSN 00074551
- iMarina
CIRCULATING ANTIGEN LEVELS IN OVARIAN-CANCER
- COLOMER, R
- GENOLLA, J
- DELCAMPO, JM
- RUIBAL, A;
Journal Of Clinical Oncology (p. 1148-1149) - 1/1/1986
10.1200/jco.1986.4.7.1148 Ver en origen
- ISSN 0732183X
MYELIN BASIC-PROTEIN AND CREATINE-KINASE BB ISOENZYME AS CSF MARKERS OF INTRACRANIAL TUMORS AND STROKE
- MATIASGUIU, J
- MARTINEZVAZQUEZ, J
- RUIBAL, A
- COLOMER, R
- BOADA, M
- CODINA, A;
Acta Neurologica Scandinavica (p. 461-465) - 1/1/1986
10.1111/j.1600-0404.1986.tb04585.x Ver en origen
- ISSN 00016314
Circulating CA 15.3 levels in breast cancer. Our present experience.
- Ramon Colomer
- Alvaro Ruibal
- Matilde Navarro
- Gloria Encabo
- Luis Alfonso Sole
- Luis Salvador
International Journal Of Biological Markers (p. 89-92) - 1/1/1986
- ISSN 03936155
- iMarina
Serum CA 15.3 levels in patients with non-tumoral diseases, and establishment of a threshold for tumoral activity. Results in 1219 patients.
- Alvaro Ruibal
- José Genollá
- Mariona Rosell
- José María Gris
- Ramón Colomer
International Journal Of Biological Markers (p. 159-160) - 1/1/1986
- ISSN 03936155
- iMarina
CA 15.3 - EARLY RESULTS OF A NEW BREAST-CANCER MARKER
- COLOMER, R
- SOLE, LA
- NAVARRO, M
- ENCABO, G
- RUIBAL, A
- SALVADOR, L;
Anticancer Research (p. 683-684) - 1/7/1986
- ISSN 02507005
- iMarina
Tratado de oncología
- Hernán Cortés-Funes
- Ramón Colomer Bosch
- Emilio Alba Conejo
1/1/2009
- ISBN 9788492620166
- iMarina
Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study
- J Albanell
- E Ciruelos
- R Colomer
- J De la Haba
- M Martin
- De Salas-Cansado
- B Munoz-Molina
- C Tournier
- P Thuresson
- W Schleich
1/1/2015
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- MD Fenor De La Maza
- V Pacheco-Barcia
- JM Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondejar
- O Donnay
- B Obispo
- R Colomer
- JM Sanchez-Torres
1/1/2017
- iMarina
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …
- Chau Dang
- Michael S Ewer
- Suzette Delaloge
- Jean-Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Claudia Vieira
- Luis de la Cruz Merino
- Jennifer Lucas
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Sandra M Swain
1/1/2018
- iMarina
Tratamiento hormonal del cáncer
- Ramón Colomer Bosch
- M L Amador
- J González Cortijo
- MV Tornamira
Oncología En Atención Primaria / Coord. Por Vicente Valentín Maganto - 1/1/2003
- iMarina
Fatty acid metabolism in cancer cell survival: A new anti-cancer target
- Porta, Rut
- Colomer, Ramon
- Puig, Teresa;
Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011
- iMarina
Breast cancer-Anaemia and the Value of Erythropoietin (BRAVE): preliminary results from a study of the efficacy of epoetin beta 30,000 IU once weekly in patients with metastatic breast cancer receiving chemotherapy
- Marangolo, M.
- Lang, I.
- Beato, C.
- Colomer, R.
- Ukarma, L.;
European Journal Of Cancer, Supplement (p. 388-388) - 1/1/2005
- ISSN 13596349
- iMarina
Epoetin beta in patients with metastatic breast cancer receiving chemotherapy: Results from the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
Journal Of Clinical Oncology (p. 467-764S) - 1/1/2005
- ISSN 0732183X
- iMarina
Breast cancer-Anaemia and the Value of Erythropoietin (BRAVE): preliminary results from a study of the efficacy of epoetin beta 30,000 IU once weekly in patients with …
- M Marangolo
- I Lang
- C Beato
- R Colomer
- L Ukarma
(p. 388-388) - 1/1/2005
- iMarina
Phase I/II trial of capecitabine and gefitinib in patients with advanced colorectal cancer after failure of first-line therapy
- Gravalos, C.
- Escudero, P.
- Jimeno, A.
- Sevilla, I.
- Vega-Villegas, M. E.
- Alonso, V.
- Juez, I.
- Garcia-Carbonero, R.
- Bovio, H.
- Cortes-Funes, H.;
European Journal Of Cancer, Supplement (p. 198-199) - 1/1/2005
- ISSN 13596349
- iMarina
Discovery of DNAa hypermethylation targets associated with bladder cancer progression using CpG island microarrays
- Menendez, J A
- Aleman, A
- Vazquez-Martin, A
- Adrien, L
- Colomer, R
- Lopez, L
- Cordon-Cardo, C
- Esteller, M
- Belbin, T
- Sanchez-Carbayo, M
European Journal Of Cancer, Supplement (p. 44-44) - 1/1/2006
10.1016/s1359-6349(06)70142-2 Ver en origen
- ISSN 13596349
Using psychometric and clinimetric techniques to select items for use in a new instrument to measure cancer-related fatigue
- Baro, E
- Carulla, J
- Valentin, V
- Rodriguez, C
- Gascon, P
- Garcia-Mata, J
- Colomer, R
- Cassinello, J
- Herdman, M
- Gasquet, J A
- Sanchez, J
Value In Health (p. A203-A203) - 1/1/2006
10.1016/s1098-3015(10)63204-4 Ver en origen
- ISSN 10983015
The development of a new scale for assessing patient perceptions of cancer-related fatigue (CRF)
- Carulla, J.
- Valentin, V.
- Rodriguez, C. A.
- Gascon, P.
- Garcia-Mata, J.
- Colomer, R.
- Cassinello, J.
- Baro, E.
- Gasquet, J. A.
- Sanchez, J.;
Annals Of Oncology (p. 296-296) - 1/1/2006
- ISSN 09237534
- iMarina
Differential impact of single agent erlotinib in patients (P) with advanced or metastatic NSCLC untreated or pretreated with chemotherapy: Univariate and multivariate analysis
- Felipe Cardenal
- Hernan Cortes
- Ramon Colomer
- Pilar Garrido
- Amalia Velasco
- Cinta Pallares
- Alfonso Gurpide
- Manuel Cobo
- M Amador
- Bartomeu Massuti
Annals Of Oncology (p. 216-216) - 1/1/2006
- ISSN 09237534
- iMarina
Correlation between HER2/neu overexpression/amplification and clinicopathologic parameters in advanced gastric cancer (AGC) patients (pts): A prospective study.
- C Gravalos
- A Marquez
- R Colomer
- R Garcia-Carbonero
- J Sastre
- F Rivera
- A Saenz-Cusi
- A Velasco
- C Guzman
- A Jimeno
Journal Of Clinical Oncology (p. 467-200S) - 1/1/2006
- ISSN 0732183X
- iMarina
Development of a high-sensitive antibody-based protein array system that quantitatively detects serum Fatty Acid Synthase (sFASN) in breast cancer: correlation with Her-2/neu (erbB-2) expression and trastuzumab efficacy
- Menendez, J. A.
- Vazquez-Martin, A.
- Colomer, R.;
European Journal Of Cancer, Supplement (p. 44-44) - 1/1/2006
10.1016/s1359-6349(06)70141-0 Ver en origen
- ISSN 13596349
[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]
- Sanchez-Munoz, A
- Gravalos Castro, C
- Colomer Bosch, R
- Garcia Velasco, A
- Garcia, J P
- Cortes-Funes, H
Revista Clinica Espanola (p. 597-598) - 1/1/2003
- ISSN 15781860
- iMarina
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.
- Hitt, R
- Paz-Ares, L
- Hidalgo, M
- Colomer, R
- Brandariz, A
- Pena, M
- Alvarez-Vicent, J
- Hornedo, J
- Cortes-Funes, H;
Seminars In Oncology (p. S19-20) - 1/12/1997
- ISSN 00937754
- iMarina
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization
- Arranz, R.
- García-Alfonso, P.
- Sobrino, P.
- Zamora, P.
- Carrión, R.
- García-Laraña, J.
- Pérez, G.
- López, J.
- Lavilla, E.
- Lozano, M.
- Rayón, C.
- Colomer, R.
- González Barón, M.
- Flores, E.
- Pérez-Manga, G.
- Fernández-Rañada, J.M.
Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998
Editor: American Society of Clinical Oncology
10.1200/jco.1998.16.4.1538 Ver en origen
- ISSN 0732183X
- ISSN/ISBN 0732-183X
- Dialnet
- iMarina
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer
- Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R
Clinical Breast Cancer (p. 286-91) - 1/1/2003
10.3816/cbc.2003.n.034 Ver en origen
- ISSN 15268209
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators
Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020
- ISSN 0732183X
- iMarina
Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater
1/1/1996
- iMarina
Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez
1/1/2001
- iMarina
Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz
1/1/2002
- iMarina
Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo
1/1/2003
- iMarina
Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia
1/1/2004
- iMarina
Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín
1/1/2007
- iMarina
Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís
1/1/2016
- iMarina
El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Javier Abel Menéndez Menéndez (Director)
- Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo
1/1/2016
- iMarina
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Publons
-
Scopus Author ID
-
Dialnet id